Raffaele Napoli

Prof. Dr. Raffaele Napoli

Department of Translational Medical Science, University Federico II, Naples, Italy
orcid

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 1992 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
GLGiuseppe Lembo
Giuseppe Lembo
Raffaele NapoliRaffaele Napoli
Raffaele Napoli
BCB. Capaldo
B. Capaldo
VRV Rendina
V Rendina
Guido IaccarinoGuido Iaccarino
Guido Iaccarino
LSL Saccà
L Saccà
The reason why hyperinsulinemia is associated with essential hypertension is not known. To test the hypothesis of a pathophysiologic link mediated by the sympathetic nervous system, we measured the changes in forearm norepinephrine release, by using the forearm perfusion technique in conjunction with the infusion of tritiated NE, in patients with essential hypertension and in normal subjects receiving insulin intravenously (1 mU/kg per min) while maintaining euglycemia. Hyperinsulinemia (50-60 microU/ml in the deep forearm vein) evoked a significant increase in forearm NE release in both groups of subjects. However, the response of hypertensives was threefold greater compared to that of normotensives (2.28 +/- 45 ng.liter-1.min-1 in hypertensives and 0.80 +/- 0.27 ng.liter-1 in normals; P less than 0.01). Forearm glucose uptake rose to 5.1 +/- .7 mg.liter-1.min-1 in response to insulin in hypertensives and to 7.9 +/- 1.3 mg.liter-1.min-1 in normotensives (P less than 0.05). To clarify whether insulin action was due to a direct effect on muscle NE metabolism, in another set of experiments insulin was infused locally into the brachial artery to expose only the forearm tissues to the same insulin levels as in the systemic studies. During local hyperinsulinemia, forearm NE release remained virtually unchanged both in hypertensive and in normal subjects. Furthermore, forearm glucose disposal was activated to a similar extent in both groups (5.0 +/- 0.6 and 5.2 +/- 1.1 mg.liter-1.min-1 in hypertensives and in normals, respectively). These data demonstrate that: (a) insulin evokes an abnormal muscle sympathetic overactivity in essential hypertension which is mediated by mechanisms involving the central nervous system; and (b) insulin resistance associated with hypertension is demonstrable in the skeletal muscle tissue only with systemic insulin administration which produces muscle sympathetic overactivity. The data fit the hypothesis that the sympathetic system mediates the pathophysiologic link between hyperinsulinemia and essential hypertension.

17 December 2001 in Circulation
Verified
Journal Article
Closed access
PDF file
Raffaele NapoliRaffaele Napoli
Raffaele Napoli
BBBernadette Biondi
Bernadette Biondi
VGVincenzo Guardasole
Vincenzo Guardasole
MMMargherita Matarazzo
Margherita Matarazzo
FPFrancesco Pardo
Francesco Pardo
LSLuigi Saccà
Luigi Saccà
Background — Although thyroid hormone (TH) exerts relevant effects on the cardiovascular system, it is unknown whether TH also regulates vascular reactivity in humans. Methods and Results — We studied 8 patients with hyperthyroidism, basally (H) and 6 months after euthyroidism was restored by methimazole (EU). Thirteen healthy subjects served as control subjects (C). We measured forearm blood flow (FBF) by strain-gauge plethysmography during intrabrachial graded infusion of acetylcholine, sodium nitroprusside (SNP), norepinephrine, and L-NMMA (inhibitor of NO synthesis). Basal FBF (in mL · dL −1 · min −1 ) was markedly higher in H than in C (5.8±1.2 and 1.9±0.1, respectively; P <0.001) and was close to normal in EU (2.6±0.3, P <0.01 versus H). During acetylcholine infusion, FBF increased much more in H (+33±5) than in C (+14±3, P <0.01 versus H) and in EU (+20±5, P =0.01 versus H and P =NS versus C). In contrast, the response to SNP infusion was comparable in the patients and control subjects. During norepinephrine infusion, the fall in FBF was much more pronounced in H (−6±1) than in C (−0.7±0.3, P <0.005 versus H) and in EU (−1.5±0.3, P <0.01 versus H). Finally, inhibition of NO synthesis by L-NMMA decreased FBF by 2.8±0.6, 0.61±0.7, and 1.4±0.3 in H, C, and EU, respectively (H versus C and EU, P <0.05). Conclusions — In hyperthyroidism, (1) the marked basal vasodilation is largely accounted for by excessive endothelial NO production, (2) vascular reactivity is exaggerated because of enhanced sensitivity of the endothelial component, (3) the vasoconstrictory response to norepinephrine is potentiated, and (4) this abnormal vascular profile is corrected when euthyroidism is restored by medical therapy. The data demonstrate that vascular endothelium is a specific target of TH.

Verified
Journal Article
Open access
PDF file
FPFrancesca Chiara Pignalosa
Francesca Chiara Pignalosa
ADAntonella Desiderio
Antonella Desiderio
PMPaola Mirra
Paola Mirra
CNCecilia Nigro
Cecilia Nigro
GPGiuseppe Perruolo
Giuseppe Perruolo
FFFrancesca Fiory
Francesca Fiory
Diabetes mellitus (DM) is a chronic metabolic disorder characterized by hyperglycemia, responsible for the onset of several long-term complications. Recent evidence suggests that cognitive dysfunction represents an emerging complication of DM, but the underlying molecular mechanisms are still obscure. Dopamine (DA), a neurotransmitter essentially known for its relevance in the regulation of behavior and movement, modulates cognitive function, too. Interestingly, alterations of the dopaminergic system have been observed in DM. This review aims to offer a comprehensive overview of the most relevant experimental results assessing DA’s role in cognitive function, highlighting the presence of dopaminergic dysfunction in DM and supporting a role for glucotoxicity in DM-associated dopaminergic dysfunction and cognitive impairment. Several studies confirm a role for DA in cognition both in animal models and in humans. Similarly, significant alterations of the dopaminergic system have been observed in animal models of experimental diabetes and in diabetic patients, too. Evidence is accumulating that advanced glycation end products (AGEs) and their precursor methylglyoxal (MGO) are associated with cognitive impairment and alterations of the dopaminergic system. Further research is needed to clarify the molecular mechanisms linking DM-associated dopaminergic dysfunction and cognitive impairment and to assess the deleterious impact of glucotoxicity.

1 June 2007 in Growth Hormone & IGF Research
Verified
Journal Article
Closed access
JPJ.K. Powrie
J.K. Powrie
EBE.E. Bassett
E.E. Bassett
TRT. Rosen
T. Rosen
JJJ.O. Jørgensen
J.O. Jørgensen
Raffaele NapoliRaffaele Napoli
Raffaele Napoli
PSP.H. Sönksen
P.H. Sönksen

1 April 1997 in JACC
Verified
Journal Article
Closed access
Antonio CittadiniAntonio Cittadini
Antonio Cittadini
JGJessica D Grossman
Jessica D Grossman
Raffaele NapoliRaffaele Napoli
Raffaele Napoli
SKSarah E Katz
Sarah E Katz
HSHinrik Strömer
Hinrik Strömer
PDPamela S Douglas
Pamela S Douglas

14 March 2012 in Diabetes
Verified
Journal Article
Open access
Antonio CittadiniAntonio Cittadini
Antonio Cittadini
Raffaele NapoliRaffaele Napoli
Raffaele Napoli
MMMaria Gaia Monti
Maria Gaia Monti
DRDomenica Rea
Domenica Rea
SLSalvatore Longobardi
Salvatore Longobardi
LSLuigi Saccà
Luigi Saccà
Insulin resistance is a recently identified mechanism involved in the pathophysiology of chronic heart failure (CHF). We investigated the effects of two insulin-sensitizing drugs (metformin and rosiglitazone) in a genetic model of spontaneously hypertensive, insulin-resistant rats (SHHF). Thirty SHHF rats were randomized into three treatment groups as follows: 1) metformin (100 mg/kg per day), 2) rosiglitazone (2 mg/kg per day), and 3) no drug. Ten Sprague-Dawley rats served as normal controls. At the end of the treatment period (12 months), the cardiac phenotype was characterized by histology, echocardiography, and isolated perfused heart studies. Metformin attenuated left ventricular (LV) remodeling, as shown by reduced LV volumes, wall stress, perivascular fibrosis, and cardiac lipid accumulation. Metformin improved both systolic and diastolic indices as well as myocardial mechanical efficiency, as shown by improved ability to convert metabolic energy into mechanical work. Metformin induced a marked activation of AMP-activated protein kinase, endothelial nitric oxide synthase, and vascular endothelial growth factor and reduced tumor necrosis factor-α expression and myocyte apoptosis. Rosiglitazone did not affect LV remodeling, increased perivascular fibrosis, and promoted further cardiac lipid accumulation. In conclusion, long-term treatment with metformin, but not with rosiglitazone, prevents the development of severe CHF in the SHHF model by a wide-spectrum interaction that involves molecular, structural, functional, and metabolic-energetic mechanisms.